ALEXANDRIA, Va., March 3 -- United States Patent no. 12,564,625, issued on March 3, was assigned to Valneva SE (Nantes, France).

"Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus CHIKV-triangle5nsP3" was invented by Andrea Fritzer (Vienna), Andreas Meinke (Pressbaum, Austria), Urban Lundberg (Pressbaum, Austria), Mario Nebenfuhr (Vienna), Jurgen Heindl-Wruss (Vienna), Robert Schlegl (Siegenfeld, Austria) and Arnaud Leon (Nantes, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a process for producing an immunogenic live attenuated Chikungunya virus, as well as pharmaceutical compositions comprising the same."

The patent was filed ...